ReleaseWire Connect

Hot therapy which is also known as thermotherapy is the use of heat in therapy. While cold therapy is the immediate first aid particularly used in sports injuries. Hot therapy is performed to get rid of pain by using various techniques such as hot cloth, whirlpool baths, heating pad, ultrasound, and hot water bottle. On the other hand, cold therapy commonly known as cryotherapy is performed by applying an ice or gel pack. Both the therapies are no addictive and non-invasive pain relief therapies for muscles and joint pain.

The gel warmers are widely used in the medical and healthcare spectrum. They are used by private practitioners and healthcare facilities and healthcare and medical clinics spread across the world. The product is one of its kind, so the demand is immense in the market the growth prospect of the gel warmers market is boundless. Gel warmers are used to balance the body temperature of the patients and it is also used for conducting ultrasounds. Expecting mothers and or patients of breast cancers are the largest users of the gel warmers. The gel warmers market is completely dependent upon these two streams of medical science. The gel warmers market is growing fast in some of the countries of the African region which have registered a steady growth in the population of expecting mothers. The survival and growth of the Gel warmers market are also dovetailed with the treatments of breast cancer. A recent report reveals that the number of breast cancer patients are more than 1.7 billion and it is snowballing.

The term 'ultrasound treatment' is a known one, while some of us may even have undergone some kind of check-up with its assistance. As the name suggests, a Doppler Ultrasound test uses higher frequency sound waves to measure blood flow in the arteries and veins and is usually done on the arms and legs. It is a completely risk and pain free procedure as it only involves using high intensity sound waves. It is recommended by doctors to check for signs of deep vein thrombosis, superficial thrombophlebitis, arteriosclerosis or even if tumours are suspected in any of the limbs. The ultrasound Doppler market can broadly be classified into two main types based on portability- handheld and trolley based ones. The trolley based ones account for the majority sold at present but the handheld ones are expected to show larger growth because of ease of use, cheaper initial expenditure and also lower long term cost of running due to less electricity consumed as compared to trolleys.

A billion dollar medical equipment industry is lurking under the shadow of the healthcare industry which is evolving very fast. Several big international players are infusing massive funds into research and development to change the entire landscape of the medical tools and equipment industry. Reachers are mostly made of aluminum and comes as an aid for people who have problem in bending or stretching. They are available in a gamut of designs and they are portable and can be carried along. They are extremely helpful for adult citizens and also for patients who are suffering with any kind of knee or back problem. Even they come to the rescue of pregnant women, as it bars them from bending or stretching.

Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease which causes the immune system to mistakenly attack health body tissue. In SLE, body immune system can affect any part of the body, such as joints, organs, eyes, skin, etc. Often SLE can result in symptoms such as malar rash, discoid lesions, sub-acute cutaneous lesions, photosensitivity, oral ulcers, arthritis, serositis, nephropathy, neurologic involvement, thrombocytopenia, haemolytic anemia, fever, Raynaud's phenomenon, livedo reticularis, thrombosis, and myositis. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening severity. It is also called as drug-induced lupus erythematosus due to common observation against drugs such as isoniazid, hydralazine and procainamide. Currently, there is no complete treatment for SLE. While only two biologic agents have been approved by FDA to treat SLE, synthetic drugs are still the mainstay of therapy in SLE. Based on available evidence, azathioprine and mycophenolate mofetil are the drugs of first choice. Hydroxychloroquine should be considered an anchor drug in SLE because of the multiple beneficial effects of this agent.

Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment. In the world Breast cancer is the most common cancer. Breast cancer is the second most common after the lung cancer. For the treatment of this cancer Tamoxifen is one of the choice. Increasing the cancer prevalence rate in developed countries and encouragement of government organizations like WHO (World Health Organization), American Cancer Institute in the prevention are driven the Tamoxifen Market. Governments of different countries also spreading awareness about breast cancer in the people.

Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss. Neurodegenerative disease market is expected to grow at a significant pace mainly due to increasing cases of neurological disorders. The market is expected to witness advancement in the upcoming years due to launch of new type of drugs. In the Alzheimer's market, drugs like GABA receptor modulators, anti-amyloid protein agents and nicotinic and cholinergic receptor agonists are expected to influence the market growth however in the Parkinson's disease market will be driven due to launch of drugs like dopamine receptor agonists and reuptake inhibitors, glutamate receptor modulators, and adrenergic and adenosine antagonists. New players are expected to enter the market in the forecast years due to patent protection loss for major players.

Future Market Insights' published report on the global oxytocic pharmaceuticals market estimates that the market, which is presently valued at US$ 62.2 million, will expand at an impressive 9.7% CAGR to reach US$ 157.6 million value by 2026-end. In the report, titled "Oxytocic Pharmaceuticals Market: Global Industry Analysis & Opportunity Assessment, 2016-2026," Future Market Insights projects that the global market for oxytocic pharmaceuticals will remain highly fragmented due to higher prevalence of local players as opposed to multinationals and conglomerates. Nevertheless, global pharmaceutical industry leaders such as Pfizer Inc., Novartis AG, Baxter Healthcare Corporation, and Teva Pharmaceutical Industries Ltd. are also partaking in the global oxytocic pharmaceuticals market. Other leading manufacturers of oxytocic pharmaceuticals include Biofutura Pharma SpA, Ferring BV, and Fresenius Kabi AG.

Future Market Insights' report, titled "Portable Ultrasound Bladder Scanners Market: Global Industry Analysis & Opportunity Assessment, 2016-2026," delivers insights on key factors driving the growth of the portable ultrasound bladder scanner market. By the end of 2026, the global market for portable ultrasound bladder scanners is projected to incur a steady growth in terms of market value, rising from an estimated US$ 93.8 million in 2016 to US$ 170.6 million, exhibiting a 6.2% CAGR during the period.

With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global cancer supportive care products market is currently thriving at a sound pace and is anticipated to see steady growth over the next few years